VEGFA and cancer: Since the goal of VEGF antisense therapy is to inhibit cancer cell induced angiogenic signalling, experiments then were designed to evaluate the impact of reducing tumour cell expression of VFGF by antisense PS-ODNs treatment on endothelial cell growth and migration.